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In	2013	and	2014,	the	Netherlands	experienced	a	measles	
outbreak	in	orthodox	Protestant	communities	with	low	mea-
sles–mumps–rubella	vaccination	coverage.	Assessing	total	
outbreak	 costs	 is	 needed	 for	 public	 health	 outbreak	 pre-
paredness	and	control.	Total	costs	of	this	outbreak	were	an	
estimated	$4.7	million.
During May 2013–March 2014, the Netherlands was af-fected by a large measles outbreak (1). The outbreak 
began in the center of the country in an orthodox Protestant 
community and spread mainly to regions with low vacci-
nation coverage. Overall, the Netherlands has high mea-
sles–mumps–rubella (MMR) vaccination coverage, with 
>95% coverage for the first dose of MMR for children. 
However, some orthodox Protestant and anthroposophic 
communities opt out of childhood vaccination programs on 
religious grounds or on the basis of personal beliefs (2). 
In addition to the effects of disease on a society, measles 
outbreaks have economic consequences, including direct 
medical costs and productivity losses. Moreover, a measles 
outbreak demands a range of responses from the National 
Institute for Public Health and the Environment (RIVM) 
and municipal public health services (MHS). Assessing 
outbreak costs, including costs of response activities by 
public health authorities, can help in planning for future 
outbreaks and in optimizing allocation of public resources. 
Recent research on measles outbreak costs in industrial-
ized countries is scarce and has addressed hospitalizations 
costs (3), costs of imported cases of measles (4–7) or small 
outbreaks (8,9). We assessed the economic costs of a large 
measles outbreak in the Netherlands.
The Study
All physicians and laboratories are mandated to report 
measles to MHSs in the Netherlands. Each MHS records 
patient information in a national database, which includes 
information on age, postal code, date of symptoms, com-
plications, hospitalization, and source of infection. Notifi-
cations of measles cases were used to assess medical costs 
and productivity losses (online Technical Appendix, http://
wwwnc.cdc.gov/EID/article/21/11/15-0410-Techapp.pdf). 
Information on additional serologic tests and extra vac-
cinations among health care workers in hospitals were 
obtained from a study on the implementation of measles 
guidelines for hospitals (online Technical Appendix). In-
formation about vaccinations of infants and older unvac-
cinated children in response to the outbreak was retrieved 
from the national immunization register. We interviewed 
staff at MHSs and the RIVM to assess the amount of per-
sonnel time related to outbreak response activities (online 
Technical Appendix).
During the epidemic, 2,700 measles cases were re-
ported, mostly among children 5–14 years of age (Table 
1). In 329 patients, complications such as otitis media, 
pneumonia, and encephalitis developed. One child died 
from measles complications, and 181 patients were hos-
pitalized. One patient with encephalitis spent 8 months in 
a rehabilitation clinic. Of patients who consulted a physi-
cian but were not hospitalized, 199 experienced complica-
tions, mostly otitis media (104 patients) or pneumonia (75 
patients). Total estimated cost for direct health care was 
$1,255,718 (mean $465/case). An additional $365,885 
($136/case) was attributed to productivity losses and in-
formal child care losses (online Technical Appendix Table 
1). In 2013, most (85%) responding hospitals in the Neth-
erlands offered a serologic test to employees to ensure that 
they were sufficiently protected against measles (online 
Technical Appendix). Employees identified as being at 
risk for measles infection were offered an MMR vaccina-
tion. On average, 80 serologic tests led to 63 vaccinations 
per hospital for a total estimated cost of $222,203 (online 
Technical Appendix Table 2). 
At the start of the outbreak, RIVM convened a national 
outbreak management team to discuss a strategy regarding 
targeted vaccination campaigns for infants living in com-
munities with low vaccination coverage and for previously 
unvaccinated persons. A total of 6,652 infants received a 
complimentary MMR vaccination. Among children 18 
months–19 years of age, 6,948 received an MMR vaccina-
tion during July 2013–March 2014. Costs for these vac-
cinations were $299,840. During this outbreak, the RIVM 
also coordinated outbreak control, conducted enhanced 
surveillance, and responded to extensive media attention 
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(online Technical Appendix). Total costs for outbreak re-
sponse activities by the RIVM were an estimated $698,280 
($259/case). In addition, we collected information from 6 
MHSs that together had recorded more than half of all noti-
fied measles cases nationally. Their response activities in-
cluded registration and processing of cases, vaccination ac-
tivities, and advising of local authorities, professionals, and 
the general population (online Technical Appendix). Total 
estimated costs for all MHSs was $1,852,470 ($686/case).
The MHSs incurred most of the costs of the outbreak, 
followed by costs for hospitalizations (Table 2). Costs of 
outbreak response activities by the RIVM were also con-
siderable. Costs classified as other medical costs (i.e., con-
sultations with general practitioners), productivity losses, 
and costs for vaccination campaigns were among the low-
est (Table 2; online Technical Appendix Table 3).
Conclusions
The measles outbreak occurring in the Netherlands during 
2013–2014 was associated with substantial costs of ≈$4.7 
million (€3.9 million), or 0.0042% of overall health care 
costs ($113 billion in 2013) in the Netherlands. The 2,700 
reported measles cases during this outbreak resulted in an 
estimated $1,739 per case. Outbreak management costs 
were the primary cost, probably because of demands for 
expert advice, response to extensive media attention, reg-
istration of notified cases, and more surveillance activities 
than usual.
Despite being substantial, the outbreak costs in our 
study are underestimated. Because of data limitations, we 
were unable to estimate normal human immunoglobulin 
costs, patients’ traveling costs, or costs of vaccinations 
of adults or of long-term complications of disease. Also, 
reported cases in other countries have been linked to this 
outbreak, including Canada, United States, and Belgium; 
associated costs for cases exported to other countries are 
not included in our calculations. Furthermore, surveillance 
systems are affected by a degree of underreporting; there-
fore, uncertainty exists about the “true” economic costs of 
disease (10). In a previous measles outbreak in the Neth-
erlands, the estimated true number of measles cases was 
≈10 times the number of cases reported in the surveillance 
system (11). Moreover, only 47% of hospitalized cases in 
the previous outbreak were reported (12). Applying these 
data to our results, the estimated total outbreak costs would 
be ≈$0.9 million higher. Further research into the extent of 
underreporting in this outbreak is planned.
In Australia, the public health unit cost for respond-
ing to a single case of measles was $1,701 (7), a similar 
amount to our results. In the United States, costs of con-
taining an outbreak were estimated at $6,180 per case. Ad-
ditional US studies report that containment of a single im-
ported measles case resulted in even higher costs per case 
(5,6). Explanations for the higher costs in the United States 
 
 
 
Table 1. Estimated	direct	health	care	costs	during	measles	outbreak,	the	Netherlands,	2013–2014*		 
Type	of	cost	 Total	no.	patients Unit	cost,	$ 
Average	health	care	
utilization Total	cost,	$ 
Physician	consultation     
 Uncomplicated	measles,	no.	visits 2,320 37.35 0.2 17,330 
 Uncomplicated	measles,	no.	phone	calls 2,320 18.07 0.1 4,192 
 Hospitalizations,	no.	cases 181 37.35 1.0 6,760 
 Other	complicated	measles,	no.	cases 199 37.35 2.0 14,865 
 Treatment	for	pneumonia	in	general	practice,	no.	cases† 75 16.02 1.0 1,202 
Length	of	hospitalization,	d     
 General	ward 174 600 4.6 480,240 
 Intensive	care	unit 7 2,866 13.1 262,812 
 Rehabilitation 1 447 245 109,515 
Serologic	test	results,	no.	cases†   .  
 Positive	 139 21.37 1.0 2,970 
 Negative	 854 21.37 1.0 18,250 
DNA/RNA	amplification,	no.	cases‡     
 Positive	 765 251.55 1.0 192,436 
 Negative	 577 251.55 1.0 145,144 
Total    1,255,718 
*Costs	are	calculated	in	2013	US	dollars	($).	Total	number	of	measles	cases	=	2,700.	Total	cost	differs	from	sum	of	category	costs	because	of	rounding.	 
†IgM. 
‡PCR. 
 
 
 
 
Table 2. Distribution	of	costs	of	measles	outbreak,	the	
Netherlands,	2013–2014* 
Category Costs,	$ 
%	of	total	
costs 
MHS 1,852,470 39.5 
Hospitalization 852,567 18.2 
RIVM 698,280 14.9 
Production	losses 365,885 7.8 
Laboratory	tests 358,801 7.6 
Vaccination	of	children 299,840 6.4 
Vaccination	of	health	care	workers 222,203 4.7 
General	practitioner	consultation 44,350 0.9 
Total 4,694,395 100 
*Costs	are	calculated	in	2013	US	dollars	($).	Total	cost differs	slightly	from	
sum	of	category costs because	of	rounding.	MHS,	municipal	public	health	
services;	RIVM,	National	Institute	for	Public Health and	the	Environment,	
the	Netherlands.	 
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include more extensive contact tracing and higher medical 
care expenses.
The 2013–2014 measles outbreak posed considerable 
logistical challenges for MHS staff. Registration of report-
ed cases contributed especially to the increased workload 
and costs created by this measles outbreak. To reduce this 
workload during a large outbreak, information considered 
to be critical for review could be collected for most pa-
tients, who usually recover within a few days or weeks, 
while more detailed information should continue to be col-
lected for patients with complications or serious illness. 
Measles substantially affects patients’ quality of life 
(13) and their ability to perform their usual daily activi-
ties. Complications resulting from measles, such as pneu-
monia, encephalitis, and subacute sclerosing panencepha-
litis, sometimes occur a few years after the illness (14). 
Complications from measles also affect quality of life and 
incur high financial costs, as shown in the extensive reha-
bilitation care needed by a patient with encephalitis that 
resulted from this outbreak. In the Netherlands, because re-
ligious arguments affect vaccination rates (15), elimination 
of measles will be challenging. Measles outbreaks are ex-
pected to continue to cause substantial effects from disease 
and economic costs. To prepare for new outbreaks, medi-
cal costs, productivity losses, and containment costs should 
be considered. 
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